SKHX Holds a Quality Bid as Memory Peers Sell Off Into SK hynix's Nasdaq Pricing

The Book Closed Early

SK hynix's US listing is running hot into pricing. The ~$28 billion Nasdaq ADR sale is multiple times oversubscribed ahead of Thursday's print, and underwriters shut order-taking early rather than run the full marketing window. Roughly 1,000 institutions joined the call, and cornerstones Baillie Gifford, Coatue and Situational Awareness Partners jointly flagged up to $7 billion of the 177.9 million ADSs on offer.

The demand is showing up in the price, not just the order count: the deal is tracking toward roughly $166 per ADS, above the $158 reference, with the Nasdaq debut set for Friday, July 10 under the ticker SKHY. At ~$29 billion gross it would be the largest-ever US listing by a foreign company, behind only SpaceX's $85.7 billion debut last month. SKHX, the Hyperliquid perp on the KRW-denominated common share, has followed the underlying higher as that book firmed.

Why This Isn't a Chip Rally

The most useful tell isn't the size of the book — it's what the rest of memory did while SK hynix's was filling. In the same session, Micron fell more than 6%, SanDisk dropped nearly 10%, and Western Digital lost 9%. SKHX pressing higher against that tape is not a sector move; it's a flight to the one name with the scarcest product.

The scarcity is HBM. SK hynix is the lead high-bandwidth-memory supplier into Nvidia's AI stack, and the ongoing HBM shortage is what lets it command a premium bid while commodity DRAM and NAND names get sold. One analyst framed the peer weakness as expectations running ahead of fundamentals — capital is rotating out of generic memory and into the HBM leader, not into memory broadly. That concentration is the real signal underneath the 8.72% move.

What the Perp Is Pricing

SKHX tracks the value of one SK hynix common share, with the oracle converting the KRW price to USD at the prevailing FX rate — so the perp is expressing both the equity re-rate and the won. The Hyperliquid market turned over about $769 million in the past 24 hours, so there is real book behind the move rather than a thin-liquidity print.

Two things sit directly ahead. First, pricing lands Thursday and the ADRs debut Friday — a heavily oversubscribed deal that prints above reference sets up a classic sell-the-news window if the open can't clear the anchor demand. Second, the raise is 17.79 million new shares, real dilution that already pressured the Korean line on the announcement. The bull case is that HBM scarcity absorbs both; the bear case is that a premium-priced debut into a memory selloff is exactly where enthusiasm gets tested.